menu
    • menu

    Company profile for Ariceum Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ariceum Therapeutics is developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2...
    Ariceum Therapeutics is developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ariceum TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Robert-Rössle-Straße. 10 Building 79 13125 Berlin
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ariceum-therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ariceum-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Ariceum_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AtomVie Delivers First 225Ac-SSO110 Dose for Ariceum Ph1/2 Trial
    AtomVie Delivers First 225Ac-SSO110 Dose for Ariceum Ph1/2 Trial

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-supplies-the-first-patient-dose-of-225ac-sso110-for-ariceum-therapeutics-phase-12-santana-225-clinical-trial-in-extensive-stage-small-cell-lung-cancer-and-merkel-cell-carcinoma-302612102.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Ariceum Doses First Patient In SANTANA-225 Ph1/2 Trial
    Ariceum Doses First Patient In SANTANA-225 Ph1/2 Trial

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185185/0/en/Ariceum-Therapeutics-Doses-First-Patient-in-SANTANA-225-Phase-1-2-Clinical-Trial-of-225Ac-SSO110-in-Patients-with-Extensive-Stage-Small-Cell-Lung-Cancer-or-Merkel-Cell-Carcinoma.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal
    Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166030/0/en/Nusano-and-Ariceum-Therapeutics-Announce-Multi-Isotope-Supply-Agreement.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Ariceum Therapeutics Data Backs 225Ac-Sso110 For Small Cell Lung
    Ariceum Therapeutics Data Backs 225Ac-Sso110 For Small Cell Lung

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3163854/0/en/Ariceum-Therapeutics-Data-at-the-2025-European-Association-of-Nuclear-Medicine-Annual-Congress-Further-Supports-the-Advancement-of-225Ac-SSO110-for-Extensive-Stage-Small-Cell-Lung-.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Ariceum Names David Schilansky CEO to Lead Next Development Phase
    Ariceum Names David Schilansky CEO to Lead Next Development Phase

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3138971/0/en/Ariceum-Therapeutics-Appoints-David-Schilansky-as-Chief-Executive-Officer-and-Announces-New-Leadership-to-Advance-Next-Phase-of-Development.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    FDA Grants Orphan Drug Designation to Ariceum's Cancer Therapy
    FDA Grants Orphan Drug Designation to Ariceum's Cancer Therapy

    06 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-07/us-fda-grants-orphan-drug-designation-to-ariceum-therapeutics-proprietary-radiopharmaceutical-cancer-therapy

    PHARMAWEB
    06 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search